Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Children With Plaque Psoriasis (ARQ-151-216)
Public ClinicalTrials.gov record NCT04746911. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open Label, 4-Week, Phase 2, Maximal Usage Pharmacokinetics and Safety Study of ARQ-151 Cream 0.3% Administered QD in Pediatric Subjects (Ages 2 to 5 Years Old) With Plaque Psoriasis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Phase 2, open label, maximal usage PK and safety study of ARQ-151 cream 0.3% in pediatric subjects (ages 2 to 5 years old) with plaque psoriasis:
Study identification
- NCT ID
- NCT04746911
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 10 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 2 Years to 5 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 1, 2021 (Actual)
- Primary completion
- May 11, 2022 (Actual)
- Completion
- May 11, 2022 (Actual)
- Last update posted
- Aug 7, 2026
2021 – 2022
United States locations
- U.S. sites
- 16
- U.S. states
- 6
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arcutis Clinical Site 603 | Mountain Brook | Alabama | 35223 | — |
| Arcutis Clinical Site 604 | Scottsdale | Arizona | 85255 | — |
| Arcutis Clinical Site 609 | Fountain Valley | California | 92708 | — |
| Arcutis Clinical Site 618 | Los Angeles | California | 90017 | — |
| Arcutis Clinical Site 608 | Los Angeles | California | 90057 | — |
| Arcutis Clinical Site 611 | Rancho Santa Margarita | California | 92688 | — |
| Arcutis Clinical Site 610 | Boca Raton | Florida | 33428 | — |
| Arcutis Clinical Site 602 | Coral Gables | Florida | 33146 | — |
| Arcutis Clinical Site 613 | Delray Beach | Florida | 33484 | — |
| Arcutis Clinical Study Site 628 | Miami | Florida | 33125 | — |
| Arcutis Clinical Site 607 | Miami | Florida | 33155 | — |
| Arcutis Clinical Site 627 | West Lafayette | Indiana | 47906 | — |
| Arcutis Clinical Site 606 | Arlington | Texas | 76001 | — |
| Arcutis Clinical Site 619 | Frisco | Texas | 75034 | — |
| Arcutis Clinical Study Site 619 | Frisco | Texas | 75034 | — |
| Arcutis Clinical Site 605 | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04746911, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 7, 2026 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04746911 live on ClinicalTrials.gov.